Purpose
Regulatory Intelligence helps teams understand regulatory context — how agency decisions, precedents, and filing activity relate to active programs and portfolio priorities.
Data sources
- Regulatory precedent and guidance libraries
- FDA, EMA, and global agency publication feeds
- Company and asset regulatory histories
- Linked intelligence from across the Humanexa platform
How it helps
Key intelligence areas
- Regulatory precedent monitoring
- Approval pathway intelligence
- Filing activity tracking
- Agency guidance monitoring
Example questions answered
- What regulatory precedents are relevant to our current programs?
- Which approval pathways have been used for similar assets?
- Where is filing activity increasing in our therapeutic areas?
- What agency guidance should inform our regulatory strategy?
Typical outputs
- Precedent summaries
- Pathway intelligence briefs
- Filing activity reports
- Regulatory alerts
Use cases
- Regulatory affairs teams preparing submission strategies
- Medical affairs interpreting label and guidance implications
- Competitive intelligence benchmarking approval pathways
- Portfolio strategy assessing regulatory risk by therapeutic area
Humanexa uses proprietary intelligence models and continuously updated life sciences data sources to generate insights, rankings, and strategic recommendations. Specific scoring methodologies and ranking systems are not publicly disclosed.